Immune-related adverse events from immune checkpoint inhibitors: Review of risk factors in clinical practice
© Faculty of Pharmacy, Mahidol University (Thailand) 2020. Immune checkpoint inhibitors (ICIs) have significantly driven the oncology treatment landscape as they immensely shift better clinical outcomes among various type of cancers. Challenges of using this approach are, without doubt, the immune r...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Review |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/56284 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |